Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06300255Recruiting
Evaluation of the H.O.O.V.E.S. Healing Program
This study looks at a program called H.O.O.V.E.S. Healing Intensives for veterans. It aims to understand how the program helps participants.
Salt Lake City, UtahAges 18–120 - NCT06427317Recruiting
Antibiotic effectiveness study in infection patients
This study looks at how well beta-lactam antibiotics (a common type of antibiotic) work in people being treated for infections at Imperial College NHS Trust. The information may help doctors make better dosing decisions.
LondonAges 18 years+ - NCT05911217RecruitingPhase 1
CT041 treatment after chemotherapy for resected pancreatic cancer
This Phase 1 study tests whether CT041 is safe and may help prevent pancreatic cancer from coming back after it’s been removed and you’ve completed standard chemotherapy. You may be eligible if your tumor is positive for CLDN18.2 and your recovery and blood tests meet key requirements.
Beijing, Beijing MunicipalityAges 18–79 - NCT06383377Recruiting
New bone graft for tooth extraction and implant
This study tests a new bone graft material called Wishbone HA used after tooth extraction to prepare for a dental implant. It is for people who need a tooth pulled and have healthy gums and good bone support.
Louvain-la-Neuve, Brabant WallonAges 18–80 - NCT06431711Recruiting
Eye scan study for brain small vessel disease
This study uses a special eye scan (OCTA) to check the health of tiny blood vessels in the back of the eye. It may help doctors understand small vessel disease in the brain and find easier ways to monitor it.
Hangzhou, ZhejiangAges 35 years+ - NCT06431854Recruiting
New treatment program for teens with eating disorders
This trial tests a program called MINERVA for teens aged 12-17 with an eating disorder who haven't gotten better with standard treatments. The goal is to see if this new approach helps when other treatments haven't worked.
BarcelonaAges 12–17 - NCT07842640RecruitingPhase 1
Injectable treatment for overweight and obesity
This study tests an injectable medication called ASC35 to see if it is safe and tolerable for people who are overweight or obese. It may help with weight management, though it is an early-stage trial focused on safety first.
Baltimore, MarylandAges 18–65 - NCT07843693RecruitingPhase 1
Testing three arthritis drugs in healthy volunteers
This trial tests three arthritis medications in healthy people to understand how safe they are and how the body processes them. It may help in developing future treatments for conditions like rheumatoid arthritis.
Grayslake, IllinoisAges 18–65 - NCT07842991RecruitingPhase 3
A toothpaste for reducing plaque and improving gum health
This study tests a new toothpaste designed to reduce dental plaque (the sticky film on teeth) and help prevent gum problems like bleeding or swelling. If you have mild gum issues, you may be able to join and use the toothpaste for six months.
Roma, RomeAges 18–70 - NCT07849231RecruitingPhase 1
Study of an experimental drug for CALR-mutant myeloproliferative neoplasms
This trial is testing an experimental drug called DMR-001 for people with blood cancers like ET or myelofibrosis who have a specific genetic change known as a CALR mutation. The goal is to see if the drug is safe, tolerable, and helps treat the disease.
Liverpool, New South WalesAges 18 years+ - NCT07848347Recruiting
Sensitive skin study: checking how well a product is tolerated
This study tests a cosmetic product on people with sensitive skin to see how well it is tolerated. If you have sensitive skin, you may find out if this product is suitable for your skin.
Osasco, São PauloAges 18 years+ - NCT07843498RecruitingPhase 3
Testing a new weight-loss medicine in adults with overweight or obesity
This study tests a new medication called petrelintide to see how well it helps people lose weight and improve their health. It's for adults with overweight or obesity who have struggled to lose weight with diet alone.
Anniston, AlabamaAges 18 years+ - NCT07843472RecruitingPhase 3
Petrelintide for weight loss in people with heart disease
This study tests a new medication called petrelintide to help people with overweight or obesity and heart disease lose weight. It may offer a new way to manage weight and improve heart health.
Anniston, AlabamaAges 40 years+ - NCT07844967RecruitingPhase 1
How the liver affects a new medicine
This study tests a new medicine for people with mild or moderate liver problems to see how the liver affects the drug in the body. It also includes people with normal liver function for comparison.
Hefei, AnhuiAges 18 years+ - NCT07843485RecruitingPhase 3
Weight loss medication for adults with type 2 diabetes
This study tests a new medicine called petrelintide to help people with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be an option if you've struggled with weight loss through diet alone.
Los Angeles, CaliforniaAges 18 years+ - NCT05521711Recruiting
Testing an at-home route for tree nut allergy immunotherapy
This study tests how a specific form of treatment is given to people with a tree nut allergy. The goal is to find a safer, more effective way to help your body tolerate tree nuts.
Hamilton, OntarioAges 1–16 - NCT06038019Recruiting
Food allergy threshold test and prediction study
This study looks at people with suspected or known food allergies to find out how much of a food it takes to cause a reaction. It uses an oral food challenge (eating the food under medical supervision) to predict your personal threshold.
Hamilton, OntarioAges 3 months–65 years - NCT05649683Recruiting
Blood immune testing to predict melanoma response to immunotherapy
This study checks how your immune system behaves (through an immune testing process) to see if it can predict how well advanced melanoma will respond to checkpoint inhibitor treatment. It may help doctors choose the right treatment sooner, without guessing.
Nice, Alpes-maritimesAges 18 years+ - NCT06004154Recruiting
Imaging follow-up for giant cell arteritis patients
This study follows up patients with giant cell arteritis (Horton's disease) using MRI and ultrasound to see how the disease and treatment affect blood vessels over time. It aims to improve understanding of the condition and your imaging results.
ParisAges 50 years+ - NCT07847541RecruitingPhase 2
Botulinum toxin injections for jaw muscle pain
This trial tests whether botulinum toxin (Botox) injections can reduce pain in the jaw muscles for people with temporomandibular joint (TMJ) disorders that haven't improved with other treatments. It may help if you have ongoing jaw pain and muscle tightness.
IslamabadAges 18–60 - NCT07849608Recruiting
AI Tool to Assess Tumor Response After Pre-Surgery Treatment
This study is testing an AI tool (DeepTRG) that looks at tissue samples after pre-surgery treatment to see how well the tumor responded. It may help doctors better understand whether the treatment worked.
Shijiazhuang, None SelectedAges 18 years+ - NCT07849088RecruitingPhase 2
Chinese herbal medicine to protect kidneys during radiation therapy
This study tests a traditional Chinese herbal medicine (called Zhixiao Tongmai Ning) to see if it can protect your kidneys from damage caused by radiation therapy. If you have kidney cancer and are receiving radiation, this treatment might help keep your healthy kidney tissue working better.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07845032Recruiting
Online coping skills for dementia caregivers
This study tests an online program that teaches skills to help you cope with the stress of caring for someone with dementia or memory loss. It aims to see if becoming more flexible in your thinking can reduce your distress.
Logan, UtahAges 18 years+ - NCT07847073RecruitingPhase 4
Comparing eye drops for glaucoma and their effect on the optic nerve
This trial tests two eye drops—Rhopressa (netarsudil) and timolol—at lowering eye pressure in people with open-angle glaucoma. The study uses a special camera to see if treatment helps protect the nerve cells in the back of the eye.
Bloomington, IndianaAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.